Skip to main content
Premium Trial:

Request an Annual Quote

Benjamin Bulkley, Frank Witney, Lynn Busteed

Benjamin Bulkley, former senior vice president of global commercial operations for Invitrogen, has been named COO of Allscripts Healthcare Solutions, an electronic health records software manufacturer.
 

 
Transgenomic has named Frank Witney to its board of directors.
 
Witney is president, CEO and director of Panomics, and is a director of Applied Precision. He also has been president of PerkinElmer’s drug-discovery business and was COO of Packard Biosciences.
 

 
Enigma Diagnostics this week named Lynn Busteed to be its new CEO and director. Busteed was previously vice president for corporate development at Focus Diagnostics and was senior director of business development and strategic planning at Celera Genomics.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.